IT1203721B - Composti otticamente attivi ad attivita' antitosse e sedativa centrale,procedimento per la preparazione e composizioni che li contengono - Google Patents

Composti otticamente attivi ad attivita' antitosse e sedativa centrale,procedimento per la preparazione e composizioni che li contengono

Info

Publication number
IT1203721B
IT1203721B IT24430/83A IT2443083A IT1203721B IT 1203721 B IT1203721 B IT 1203721B IT 24430/83 A IT24430/83 A IT 24430/83A IT 2443083 A IT2443083 A IT 2443083A IT 1203721 B IT1203721 B IT 1203721B
Authority
IT
Italy
Prior art keywords
preparation
antitosse
procedure
optically active
active compounds
Prior art date
Application number
IT24430/83A
Other languages
English (en)
Other versions
IT8324430A0 (it
Inventor
Massimiliano Borsa
Giancarlo Tonon
Malandrino Salvatore
Original Assignee
Dompe Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Farmaceutici Spa filed Critical Dompe Farmaceutici Spa
Publication of IT8324430A0 publication Critical patent/IT8324430A0/it
Priority to IT24430/83A priority Critical patent/IT1203721B/it
Priority to EP84116334A priority patent/EP0147847B1/en
Priority to JP59281944A priority patent/JPS60252474A/ja
Priority to AT84116334T priority patent/ATE50767T1/de
Priority to DE8484116334T priority patent/DE3481510D1/de
Priority to US06/906,698 priority patent/US4699911A/en
Priority to US07/069,242 priority patent/US4764515A/en
Application granted granted Critical
Publication of IT1203721B publication Critical patent/IT1203721B/it
Priority to JP3007235A priority patent/JPH0670027B2/ja
Priority to JP3007236A priority patent/JPH0662416B2/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20—Free hydroxyl or mercaptan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT24430/83A 1983-12-29 1983-12-29 Composti otticamente attivi ad attivita' antitosse e sedativa centrale,procedimento per la preparazione e composizioni che li contengono IT1203721B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IT24430/83A IT1203721B (it) 1983-12-29 1983-12-29 Composti otticamente attivi ad attivita' antitosse e sedativa centrale,procedimento per la preparazione e composizioni che li contengono
DE8484116334T DE3481510D1 (de) 1983-12-29 1984-12-27 Optisch aktive verbindungen mit antitassiver und zentral-sedativer wirkung, ein verfahren zu deren herstellung und diese enthaltende zusammensetzungen.
JP59281944A JPS60252474A (ja) 1983-12-29 1984-12-27 （−）―３―（４―フェニル―１―ピペラジニル）―１，２―プロパンジオールを有効成分とする鎮咳剤
AT84116334T ATE50767T1 (de) 1983-12-29 1984-12-27 Optisch aktive verbindungen mit antitassiver und zentral-sedativer wirkung, ein verfahren zu deren herstellung und diese enthaltende zusammensetzungen.
EP84116334A EP0147847B1 (en) 1983-12-29 1984-12-27 Optically active compounds with antitussive and central sedative activity, a process for the preparation thereof and compositions containing the same
US06/906,698 US4699911A (en) 1983-12-29 1986-09-11 Levo and dextro dropropizine having antitussive activity
US07/069,242 US4764515A (en) 1983-12-29 1987-07-02 Antitussive and central sedative composition of d-isomer of 3-(4-phenyl-1-piperazinyl)-1,2-propanediol
JP3007235A JPH0670027B2 (ja) 1983-12-29 1991-01-24 ３−（４−フェニル−１−ピペラジニル）−１，２−プロパンジオールの光学対掌体の製法
JP3007236A JPH0662416B2 (ja) 1983-12-29 1991-01-24 （＋）−３−（４−フェニル−１−ピペラジニル）−１，２−プロパンジオールを有効成分とする鎮静剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT24430/83A IT1203721B (it) 1983-12-29 1983-12-29 Composti otticamente attivi ad attivita' antitosse e sedativa centrale,procedimento per la preparazione e composizioni che li contengono

Publications (2)

Publication Number Publication Date
IT8324430A0 IT8324430A0 (it) 1983-12-29
IT1203721B true IT1203721B (it) 1989-02-23

Family

ID=11213495

Family Applications (1)

Application Number Title Priority Date Filing Date
IT24430/83A IT1203721B (it) 1983-12-29 1983-12-29 Composti otticamente attivi ad attivita' antitosse e sedativa centrale,procedimento per la preparazione e composizioni che li contengono

Country Status (6)

Country Link
US (2) US4699911A (it)
EP (1) EP0147847B1 (it)
JP (3) JPS60252474A (it)
AT (1) ATE50767T1 (it)
DE (1) DE3481510D1 (it)
IT (1) IT1203721B (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837025A (en) * 1988-03-25 1989-06-06 Laboratoires D'hygiene Et De Dietetique Self-adhesive device for the percutaneous administration of an active ingredient
NL8801622A (nl) * 1988-06-25 1990-01-16 Stamicarbon Bereiding van enantiomeren van dropropizine.
IT1226570B (it) * 1988-08-01 1991-01-24 Bidachem Spa Procedimento di preparazione della levo- e destro-dropropizina
IT1231158B (it) * 1989-07-20 1991-11-19 Dompe Farmaceutici Spa Procedimento per la risoluzione ottica della dropropizina.
EP0591434A4 (en) * 1991-06-26 1994-09-14 Sepracor Inc Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
EP1013275A3 (en) * 1991-11-26 2001-01-10 Sepracor, Inc. Method and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
IT1254452B (it) * 1992-02-14 1995-09-25 Dompe Farmaceutici Spa N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli
IT1254993B (it) * 1992-06-24 1995-10-11 Procedimento per la preparazione degli enantiomeri della dropropizina
WO2000051582A2 (en) 1999-03-01 2000-09-08 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
IT1318650B1 (it) * 2000-07-28 2003-08-27 Dompe Spa 1,3-diossolani ad attivita' antitosse.
IT1318651B1 (it) * 2000-07-28 2003-08-27 Dompe Spa Sintesi di (+-)1,3-diossolani e loro risoluzione ottica.
CN102805746B (zh) * 2011-06-02 2016-02-10 湖南九典制药股份有限公司 一种作用于呼吸***疾病的复方化学药及其制备工艺与应用
MX2017014725A (es) * 2017-11-16 2019-05-17 Productos Farm S A De C V Dropropizina en combinacion con ambroxol en la forma farmaceutica de jarabe y tabletas.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3163649A (en) * 1964-12-29 Substituteb phenyl-piperazine
BE601394A (it) *
BE601794A (fr) * 1960-03-24 1961-09-25 Gabriel Co Mécanisme distributeur
GB938646A (en) * 1961-03-16 1963-10-02 Henri Morren New piperazine derivatives
NL275711A (it) * 1962-03-15
IT1210639B (it) * 1981-02-25 1989-09-14 Menarini Sas Prodotto: 3(4-fenil1piperazinio-1-il)-1,2-propandiolo 3(teofillin-7-il)-1propansolfonato,utilizzabile in terapia,e relativo procedimento di fabbricazione

Also Published As

Publication number Publication date
DE3481510D1 (de) 1990-04-12
JPH05222019A (ja) 1993-08-31
EP0147847A3 (en) 1986-11-26
JPS60252474A (ja) 1985-12-13
JPH0662416B2 (ja) 1994-08-17
IT8324430A0 (it) 1983-12-29
US4699911A (en) 1987-10-13
EP0147847B1 (en) 1990-03-07
US4764515A (en) 1988-08-16
JPH058688B2 (it) 1993-02-02
JPH05221864A (ja) 1993-08-31
JPH0670027B2 (ja) 1994-09-07
ATE50767T1 (de) 1990-03-15
EP0147847A2 (en) 1985-07-10

Similar Documents

Publication Publication Date Title
FI921087A0 (fi) Nya estrar av tienylkarboxylsyror och aminoalkoholer, deras kvaterniseringsprodukter och framstaellning och anvaendning av naemnda foereningar.
FI802717A (fi) Optiskt aktiva 1,4-dihydropyridiner foerfarande foer framstaellning av dessa och anvaendningen av dessa som laekemedel
FI873363A (fi) Foerfarande foer framstaellning av laekemedel med antitumoeraktivitet.
ATE102181T1 (de) Zwischenprodukte zur herstellung von 1,2,4triazolo(1,5-a>pyrimidin-2-sulfonamiden.
IT1203721B (it) Composti otticamente attivi ad attivita' antitosse e sedativa centrale,procedimento per la preparazione e composizioni che li contengono
FI892454A0 (fi) Nya bensimidazolderivat, foerfarande foer framstaellning av desamma och farmaceutisk komposition innehaollande desamma.
ATE13667T1 (de) 8-aza-16,16-difluor-prostanoide.
DE3586095D1 (de) Herstellung von lipid-vesikeln.
IT1182199B (it) Procedimento per la preparazione di composti 1,3-diossolan-4-metanolici otticamente attivi
NO875239D0 (no) Fremgangsmaate ved spalting av 1,4-dihydropyridinderivater i optisk aktive isomerer.
NO874575L (no) Fremgangsmaate til fremstilling av fiberarmerte komposittmaterialer inneholdende polyarylensulfidsulfon.
EP0284371A3 (en) Novel optically active benzene derivatives, process for producing the same and liquid-crystalline substances containing said derivatives as active ingredient and optical switching elements
FI873429A (fi) Oftalmologiska kompositioner foer behandling av nervdegenerationer.
DE3581382D1 (de) Herstellung von ether/etheralkohol-zusammensetzungen.
FI863122A0 (fi) Anordning foer borttagning och frammatning av arbetsstycken, ett i taget, fraon en hoeg.
NO165595C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5,6,7-tetrahydrotiazolo<5,4-c>pyridinderivater.
IT8022735A0 (it) Procedimento di preparazione dicomposti arilossialcanoici otticamente attivi.
IT8423197A0 (it) Procedimento per la preparazione di 1,3-bis (3-amminofenossi) benzene.
ES2061712T3 (es) Nuevos derivados sustituidos de 20,21-dinoreburnamenina, su procedimiento de preparacion y los nuevos productos intermedios asi obtenidos, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
DK467983A (da) Mikroporoes ferrosilicat og fremgangsmaade til fremstilling af samme
NO904496D0 (no) Fremgangsmaate for fremstilling av optisk aktive tiazetokinolin-3-karboksylsyreforbindelser.
ES498876A0 (es) Procedimiento para preparar compuestos de anillos heteroci- clicos 2,2,6,6-tetrametil-4-pireridil-sustituidos
IT1163725B (it) Diuretani, procedimento per la fabbricazione di questi composti nonche' mezzi erbicidi selettivi che li contengono
FR2758325B1 (fr) Composes tetracycliques aromatiques de type retinoide leur procede de preparation et leur utilisation pour la fabrication de compositions pharmaceutiques et cosmetiques
ES2004215A6 (es) Procedimiento para preparar quinazolinas tetraciclicas